C22H19N3O4, 171596-29-5

Post Date:
Jan 22,2018
Expiry Date:
Jan 22,2019
Detailed Description:
Cas No. :171596-29-5 Quantity: 1.39Kilograms
Specs:97.5-102%
Payment Method: 100% T/T in advance
A PDE5 inhibitor used for treating erectile dysfunction (ED) and for the treatment of pulmonary arterial hypertension.
This product can be used in treating the signs and symptoms of benign prostatic hyperplasia (BPH) as well as a combination of BPH and erectile dysfunction (ED) .
CAS Registry Number:
171596-29-5
Synonyms:
;IC-351;(6r,12ar)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione;Cialis;(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione;(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-3,4,6,6a,7,11b,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-1(2H)-one;Tadanafil;
Molecular Formula:
C₂₂H₂₃N₃O₃
Molecular Weight:
377.44
Molecular Structure:

Offter to Sell